By averaging the electroencephalogram (EEG) or the magnetoencephalogram (MEG) of waking man in a manner time-locked to the onset of self-initiated volitional acts, movement-related potentials (or magnetic fields) can be recorded. In the preparation period, a slowly increasing cortical negatively called the Bereitschaftspotential (BP) or readiness potential, can be recorded. The BP precedes all our self-initiated (i.e. endogenous or willed) movements and actions by 1 sec or more prior to the onset of muscular contraction. The BP has 2 principal components, an early one which is bihemispherically symmetric, even prior to unilateral movements, and a late one which is lateralized towards the contralateral hemisphere. We have provided evidence (which was confirmed by regional cerebral blood flow studies) that the principal cortical generator producing the early component is the so called supplementary motor area ("SMA"), whereas the late asymmetric (contralateral) component is generated by the primary (rolandic) motor area, MI. The early "SMA"-related BP component may have motivational, intentional or timing properties, while the late component is related to synaptic facilitation in the contralateral MI area in preparation for the final pyramidal tract volley. In motor learning, the frontal areas are activated in both DC-potential recordings and emission CT experiments. The complete role of the "SMA" is not yet clear. However, it obviously has to determine the right moment to start a movement including the timing of single movements in motor sequences. It is particularly strongly activated in bimanual tapping of difficult rhythms.
Download full-text PDF |
Source |
---|
Background: Alzheimer's disease (AD) agitation is a distressing neuropsychiatric symptom characterized by excessive motor activity, verbal aggression, or physical aggression. Agitation is one of the causes of caregiver distress, increased morbidity and mortality, and early institutionalization in patients with AD. Current medications used for the management of agitation have modest efficacy and have substantial side effects.
View Article and Find Full Text PDFBackground: OLX-07010 is an oral small molecule inhibitor of tau self-association that prevented the accumulation of tau aggregates in the htau mouse model expressing wild type human CNS tau isoforms and in P301L tau JNPL3 mice using chronic treatment by administration in diet (Davidowitz et al., 2020, PMID: 31771053; 2023 PMID:37556474). A therapeutic study of JNPL3 mice with chronic treatment from 7-12 months of age inhibited the progression of tau aggregation and improved motor coordination.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Temple University, Philadelphia, PA, USA.
Background: Race differences on cognitive tests have been widely reported and attributed to psychosocial factors. Cognitive assessment via performance-based tests of everyday functioning may be less influenced by psychosocial factors, offering ecologically valid and less/unbiased measurement. This study examined differences between Black/African American and White older adults on traditional cognitive tests, self/informant report of everyday function, and a sensitive performance-based test of everyday function called the Naturalistic Action Task (NAT).
View Article and Find Full Text PDFAlzheimers Dement
December 2024
NIA-Layton Aging & Alzheimer's Disease Research Center, Portland, OR, USA.
Background: Agitation is one of the most challenging behaviors exhibited by people with cognitive decline, causing distress in caregivers, earlier placement into long-term care and faster disease progression. In order to better manage agitated behaviors in people with cognitive decline, it is important to identify associated factors. The MODERATE (Monitoring Dementia-Related Agitation Using Technology Evaluation) study aims to characterize agitation using technology and identify precipitants (behavioral or environmental) of agitation.
View Article and Find Full Text PDFNeurol Res Pract
January 2025
Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
Background: Apraxia is a motor-cognitive disorder that primary sensorimotor deficits cannot solely explain. Previous research in stroke patients has focused on damage to the fronto-parietal praxis networks in the left hemisphere (LH) as the cause of apraxic deficits. In contrast, the potential role of the (left) primary motor cortex (M1) has largely been neglected.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!